Evaluation of the Diagnostic Sensitivity of the VIASURE Leishmania Real-Time PCR Detection Kit Prototype for the Diagnosis of Cutaneous and Visceral Leishmaniasis

dc.contributor.authorAlbert Arnau
dc.contributor.authorAlba Abràs
dc.contributor.authorCristina Ballart
dc.contributor.authorAnna Fernández‐Arévalo
dc.contributor.authorMary Cruz Torrico
dc.contributor.authorSílvia Tebar
dc.contributor.authorTeresa Llovet
dc.contributor.authorMontserrat Gállego
dc.contributor.authorCarmen Muñoz
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T15:18:33Z
dc.date.available2026-03-22T15:18:33Z
dc.date.issued2023
dc.descriptionCitaciones: 3
dc.description.abstractLeishmaniasis is a parasitic disease with clinical presentations that vary from asymptomatic infection to cutaneous, mucocutaneous, or visceral disease. Global change, with migratory movements and travels, among others, has had an impact on the presentation of the clinical forms of leishmaniasis in a given area, hindering its diagnosis. The traditional parasitological techniques have limited sensitivity, and currently, there is no reference or gold-standard molecular diagnostic method. The aim of this study was to evaluate the effectivity of the VIASURE <i>Leishmania</i> Real-Time PCR Detection Kit prototype (CerTest Biotec, Zaragoza, Spain) for the diagnosis of autochthonous and imported leishmaniasis in comparison with two other commercialized molecular kits: STAT-NAT® <i>Leishmania</i> spp. (Sentinel, Milano, Italy) and <i>Leishmania</i> spp. Real-TM PCR Kit (Sacace Biotechnologies, Como, Italy). Four species of <i>Leishmania</i>, <i>L. infantum</i>, <i>L. major</i>, <i>L. braziliensis</i>, and <i>L. panamensis</i>, were targeted to assess analytical sensitivity, whereas diagnostic sensitivity was evaluated by studying a panel of 49 DNA samples from patients with suspected or confirmed <i>Leishmania</i> infection. The prototype could detect all the New and Old World species studied and achieved a limit of detection of 5 × 10<sup>-5</sup> ng DNA/<i>μ</i>L in all species. Also, it allowed the diagnosis of autochthonous and imported cases of cutaneous and visceral leishmaniasis (VL). Diagnostic sensitivity was 81.8% for the prototype and 100% for the Sacace kit (27 and 33 positive samples detected, respectively). The STAT-NAT® kit failed to detect <i>Vianna</i> species. The VIASURE <i>Leishmania</i> Real-Time PCR Detection Kit prototype was found to have good analytical and diagnostic sensitivity. Using a simple protocol and ready-to-use reagents, results are obtained quickly and are easy to interpret. The evaluation results indicate that the test is a promising candidate for routine diagnosis of cutaneous leishmaniasis and VL in endemic countries, but more studies are necessary to address its sensitivity and specificity.
dc.identifier.doi10.1155/2023/1172087
dc.identifier.urihttps://doi.org/10.1155/2023/1172087
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/51613
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofTransboundary and Emerging Diseases
dc.sourceUniversitat de Girona
dc.subjectVisceral leishmaniasis
dc.subjectLeishmaniasis
dc.subjectGold standard (test)
dc.subjectLeishmania infantum
dc.subjectLeishmania
dc.subjectCutaneous leishmaniasis
dc.subjectLeishmania braziliensis
dc.subjectBiology
dc.subjectPolymerase chain reaction
dc.subjectVirology
dc.titleEvaluation of the Diagnostic Sensitivity of the VIASURE Leishmania Real-Time PCR Detection Kit Prototype for the Diagnosis of Cutaneous and Visceral Leishmaniasis
dc.typearticle

Files